Works matching DE "DRUG approval"

Results: 5000

What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.

Published in:

2007

By:

Dodge, Tonya;
Kaufman, Annette

Publication type:

Journal Article

Recent developments in atypical antipsychotic medications.

Published in:

1998

By:

Shore, David

Publication type:

Editorial

Pediatric immune-mediated skin diseases: a review of advancements in biologics and JAK inhibitor treatments.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 5, p. 192, doi. 10.1007/s40267-025-01160-6

By:

Darchini-Maragheh, Emadodin;
Moussa, Anthony

Publication type:

Article

Effective treatments for respiratory syncytial virus infection in children remain elusive but prevention tools are now available.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 5, p. 177, doi. 10.1007/s40267-025-01157-1

By:

Shirley, Matt

Publication type:

Article

Comment on: 'Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA adverse event reporting system database'.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 6, p. 1873, doi. 10.1111/bcp.70089

By:

Masuda, Rikuto;
Noguchi, Yoshihiro;
Kobayashi, Ryo;
Yoshimura, Tomoaki

Publication type:

Article

Recent ADC Approvals and Their Impact on the Breast Cancer Space.

Published in:

Oncology (08909091), 2025, v. 39, n. 4, p. 138

By:

Iyengar, Neil M.

Publication type:

Article

New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 665, doi. 10.3390/ph18050665

By:

Bozzatello, Paola;
Novelli, Roberta;
Schisano, Rebecca;
Brasso, Claudio;
Rocca, Paola;
Bellino, Silvio

Publication type:

Article

Thrombopoietic agents enhance bone healing in mice, rats, and pigs.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 1, p. 125, doi. 10.1093/jbmr/zjae191

By:

Childress, Paul J;
Nielsen, Jeffery J;
Bemenderfer, Thomas B;
Dadwal, Ushashi C;
Chakraborty, Nabarun;
Harris, Jonathan S;
Bethel, Monique;
Alvarez, Marta B;
Tucker, Aamir;
Wessel, Alexander R;
Millikan, Patrick D;
Wilhite, Jonathan H;
Engle, Andrew;
Brinker, Alexander;
Rytlewski, Jeffrey D;
Scofield, David C;
Griffin, Kaitlyn S;
Shelley, W Christopher;
Manikowski, Kelli J;
Jackson, Krista L

Publication type:

Article

Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013–2024).

Published in:

Health & Quality of Life Outcomes, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12955-025-02386-8

By:

Xie, Yan;
Liu, Yang;
Qin, Yunhe;
Yin, Geng;
Chen, Xiaoyuan;
Xie, Qibing

Publication type:

Article

Keratoconus treatment a 'modern-day miracle' through decades of collaboration.

Published in:

Ocular Surgery News, 2025, v. 43, n. 10, p. 3

By:

Lindstrom, Richard L.

Publication type:

Article

JAK-STAT inhibitors in noninfectious uveitis – A review.

Published in:

Indian Journal of Ophthalmology, 2025, v. 73, n. 6, p. 807, doi. 10.4103/IJO.IJO_61_25

By:

Pyare, Richa;
Shaikh, Nawazish;
Sen, Ahana;
Kene, Rakshita;
Bagri, Narendra;
Janarthanan, Mahesh;
Chawla, Rohan;
Ramanan, Athimalaipet V;
Dutta Majumder, Parthopratim

Publication type:

Article

Patient Information Sheet.

Published in:

Brown University Child & Adolescent Psychopharmacology Update, 2025, v. 27, n. 6, p. 9, doi. 10.1002/cpu.30981

By:

Knopf, Alison

Publication type:

Article

Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer.

Published in:

Oncology (08909091), 2014, v. 28, n. 3, p. 186

By:

O'SULLIVAN, CIARA C.;
CONNOLLY, ROISIN M.

Publication type:

Article

Neoadjuvant Pertuzumab: the Exception That Proves the Rule?

Published in:

Oncology (08909091), 2014, v. 28, n. 3, p. 197

By:

BURSTEIN, HAROLD J.

Publication type:

Article

Pertuzumab: Increasing the Options.

Published in:

Oncology (08909091), 2014, v. 28, n. 3, p. 199

By:

NUNES, RAQUEL;
SWAIN, SANDRA M.

Publication type:

Article

A Comparison of FDA and EMA Drug Approval: Implications for Drug Development and Cost of Care.

Published in:

Oncology (08909091), 2013, v. 27, n. 12, p. 1195

By:

HOWIE, LYNN J.;
HIRSCH, BRADFORD R.;
ABERNETHY, AMY P.

Publication type:

Article

FDA Approves Afatinib for Advanced Lung Cancer.

Published in:: Oncology (08909091), 2013, v. 27, n. 8, p. 813
Publication type:: Article

Fifteen Years of Anti-HER2 Therapy.

Published in:

Oncology (08909091), 2013, v. 27, n. 3, p. 151

By:

Davidson, Nancy E.

Publication type:

Article

FDA Approves Regorafenib (Stivarga) for GIST.

Published in:: Oncology (08909091), 2013, v. 27, n. 3, p. 164
Publication type:: Article

Early results of mTOR inhibitor for triple-negative breast cancer.

Published in:: Oncology (08909091), 2012, v. 26, n. 10, p. 931
Publication type:: Article

FDA Approves Aflibercept (Zaltrap) for Metastatic Colorectal Cancer.

Published in:: Oncology (08909091), 2012, v. 26, n. 9, p. 842
Publication type:: Article

FDA Approves Regorafenib (Stivarga) for Metastatic Colorectal Cancer.

Published in:: Oncology (08909091), 2012, v. 26, n. 10, p. 896
Publication type:: Article

FDA Approves Liposomal Vincristine (Marqibo) for Rare Leukemia.

Published in:: Oncology (08909091), 2012, v. 26, n. 9, p. 841
Publication type:: Article

FDA Grants Imatinib(Gleevec) Full Approval for Adjuvant Treatment of GIST.

Published in:: Oncology (08909091), 2012, v. 26, n. 3, p. 264
Publication type:: Article

Vismodegib Granted FDA Approval for Treatment of Basal Cell Carcinoma.

Published in:: Oncology (08909091), 2012, v. 26, n. 2, p. 174
Publication type:: Article

Sequencing of Therapies in Advanced Prostate Cancer.

Published in:

Oncology (08909091), 2012, v. 26, n. 1, p. 82

By:

DREICER, ROBERT

Publication type:

Article

The Year in Oncology: Breakthroughs and Controversies.

Published in:: Oncology (08909091), 2011, v. 25, n. 14, p. 1318
Publication type:: Article

FDA Approves Vemurafenib for Treatment of Metastatic Melanoma.

Published in:: Oncology (08909091), 2011, v. 25, n. 10, p. 906
Publication type:: Article

FDA Approves Brentuximab Vedotin for Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma.

Published in:: Oncology (08909091), 2011, v. 25, n. 10, p. 904
Publication type:: Article

Putting Provenge in Perspective.

Published in:

Oncology (08909091), 2011, v. 25, n. 3, p. 255

By:

Moul, Judd W.

Publication type:

Article

Prostate Cancer Immunotherapy: the Role for Sipuleucel-T and Other Immunologic Approaches.

Published in:

Oncology (08909091), 2011, v. 25, n. 3, p. 261

By:

Arlen, Philip M.

Publication type:

Article

FDA and Avastin: Crossroads in an Era of Targeted Therapies.

Published in:

Oncology (08909091), 2010, v. 24, n. 11, p. 989

By:

Tripathy, Debu

Publication type:

Article

Dendreon vs CMS: Why the Provenge Coverage Controversy Is Bigger Than Just One Product.

Published in:

Oncology (08909091), 2010, v. 24, n. 10, p. 881

By:

Baghdadi, Ramsey

Publication type:

Article

Use of Erlotinib or Gefitinib as Initial Therapy in Advanced NSCL.

Published in:

Oncology (08909091), 2010, v. 24, n. 5, p. 392

By:

Oxnard, Geofrey R.;
Miller, Vincent A.

Publication type:

Article

Announcements.

Published in:: Oncology (08909091), 2010, v. 24, n. 2, p. 119
Publication type:: Article

Update on Eltrombopag for ITP.

Published in:

Oncology (08909091), 2009, v. 23, n. 13, p. 1177

By:

Bussel, James B.

Publication type:

Article

Eltrombopag for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura.

Published in:

Oncology (08909091), 2009, v. 23, n. 13, p. 1171

By:

Andrew Dmytrijuk;
Robie-Such, Kathy;
Rieves, Dwaine;
Pazdur, Richard

Publication type:

Article

Ofatumumab Receives Approval for CLL.

Published in:: Oncology (08909091), 2009, v. 23, n. 12, p. 1103
Publication type:: Article

FDA Approves Cervical Cancer Vaccine.

Published in:: Oncology (08909091), 2009, v. 23, n. 12, p. 1009
Publication type:: Article

ODAC Recommends Approval of Pegylated Interferon Alfa-2b for Malignant Melanoma.

Published in:: Oncology (08909091), 2009, v. 23, n. 11, p. 928
Publication type:: Article

Pazopanib Receives Unanimous FDA Panel Approval Recommendation.

Published in:: Oncology (08909091), 2009, v. 23, n. 11, p. 928
Publication type:: Article

Pralatrexate Approved for Relapsed or Refractory Peripheral T-cell Lymphoma.

Published in:: Oncology (08909091), 2009, v. 23, n. 11, p. 921
Publication type:: Article

Bendamustine Study Demonstrates Significant Improvement in Overall Response and Progression- Free Survival in CLL Patients.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 850
Publication type:: Article

New Drug Application Filed for Pixantrone.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 825
Publication type:: Article

KRAS Safety Update Added to Panitumumab Prescribing Information.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 814
Publication type:: Article

Degarelix for Advanced Prostate Cancer Gets Trade Name.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 810
Publication type:: Article

New Opioid Pain Reliever Approved With Required Risk- Reduction Plan.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 810
Publication type:: Article

Accelerated Approval Granted for Bevacizumab in Glioblastoma.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 810
Publication type:: Article

FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer.

Published in:: Oncology (08909091), 2009, v. 23, n. 10, p. 810
Publication type:: Article

Announcements.

Published in:: Oncology (08909091), 2009, v. 23, n. 9, p. 743
Publication type:: Article